DoD Autism, Clinical Trial Award

The ARP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ASD. Applications are strongly encouraged to address one of the FY23 ARP Clinical Trial Award Areas of Interest. If the proposed study does not address an Area of Interest, an explanation of how the study addresses an important problem with respect to individuals with ASD must be provided. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), behavioral interventions, devices, clinical guidance, and/or emerging approaches and technologies. Funding from this award mechanism must support a clinical trial and may not be used for preclinical research studies.